Fildena Super Active, like other medications containing sildenafil citrate, may require dosage adjustment for individuals with kidney issues. Sildenafil is primarily metabolized in the liver and excreted from the body through the kidneys. Therefore, individuals with impaired kidney function may experience slower clearance of the medication from their system, leading to an increased risk of side effects or adverse reactions.

In individuals with mild to moderate kidney impairment, dosage adjustment of Fildena Super Active may be necessary to reduce the risk of complications. This adjustment typically involves lowering the dose or increasing the dosing interval to avoid accumulation of the medication in the body.

For individuals with severe kidney impairment or end-stage renal disease (ESRD), the use of Fildena Super Active may be contraindicated or require careful monitoring under the guidance of a healthcare provider. In some cases, alternative treatment options may be recommended.

It's essential for individuals with kidney issues to consult with their healthcare provider before using Fildena Super Active or any medication containing sildenafil. A healthcare provider can assess kidney function, evaluate the potential risks and benefits of treatment, and determine the appropriate dosage regimen based on individual health status and medical history. Additionally, individuals should follow their healthcare provider's recommendations regarding dosage, frequency of use, and monitoring for any adverse effects or complications.